Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |